Adagene Inc. American Depositary Shares
ADAG
ADAG: Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
moreShow ADAG Financials
Recent trades of ADAG by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ADAG's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on ADAG's company Twitter account
Number of mentions of ADAG in WallStreetBets Daily Discussion
Recent insights relating to ADAG
Recent picks made for ADAG stock on CNBC
ETFs with the largest estimated holdings in ADAG
Flights by private jets registered to ADAG